Third Party Access Agreement Service Descriptions

TPA's will be charged in accordance with the below table. 


Included in the SOW price is the provision of two 'Standard' TPA's. 


Any amendments and/or renewals of, or upgrades to 'Enhanced' or 'Premium' TPAs and /or the provision of additional TPAs (over and above two standard TPAs) will be charged in accordance with the below table.

 

Package

Description

Fees

Standard

•Submission of Diaceutics inhouse Third Party Access Agreement to third party licensee and execution

•Client must provide third party licensee access to the licensed data

•No direct support from Diaceutics – inquiries and licensed data verification requests must be submitted by client

•No changes in business rules, delivery or schema

Included in SOW price for a maximum of 2 TPAs per SOW

 

≥ 3 TPAs will be charged at $1,000 per TPA

(excl. VAT/ GST)

Enhanced

•Submission of Diaceutics inhouse Third Party Access Agreement to third party licensee and execution

•Third party licensee may access existing licensed data via S3 bucket set up by Diaceutics

•No direct support from Diaceutics – inquiries and licensed data verification requests must be submitted by client

•No changes in business rules, delivery or schema

$3,000 per TPA (excl. VAT/ GST)

Premium

•Submission of Diaceutics inhouse Third Party Access Agreement to third party licensee and execution

•Third party licensee may access existing licensed data via S3 bucket set up by Diaceutics

•Includes 60-minute licensed data/ content training during the license term

•Includes up to 5-hours of advisory support during the license term (whereby third party licensee may submit questions and data verification requests directly to Diaceutics)

•No changes in business rules, delivery or schema

$6,000 per TPA (excl. VAT/ GS

 

About Diaceutics
At Diaceutics, our mission is to redefine commercialization for diagnostic-driven therapies, so every eligible patient is found, diagnosed and receives the right therapy at the right time.  
Share:

Newsletter sign up

Sign up to our bi-weekly newsletter covering the latest insights to optimize commercialization of diagnostic driven therapies to help empower your decisions.

READY TO DO COMMERCIALIZATION DIFFERENTLY?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.